SUNSHINE BIOPHARMA
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 4 million people worldwide since it first appeared in December 2019. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness.
SUNSHINE BIOPHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2006-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.sunshinebiopharma.com
Total Employee:
1+
Status:
Active
Contact:
514-764-9698
Email Addresses:
[email protected]
Total Funding:
21.91 M USD
Technology used in webpage:
Google Maps Product Schema Offer Schema WooCommerce WooCommerce Add To Cart PayPal WPForms WooCommerce Checkout Astra Theme Essential Addons For Elementor
Similar Organizations
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
EGenesis
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Kronos Bio
Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Oisin Biotechnologies
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Point Biopharma
Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tonix Pharmaceuticals
Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-10-20 | Nora Pharma | Nora Pharma acquired by Sunshine Biopharma | 30 M CAD |
Investors List
RB Capital Partners
RB Capital Partners investment in Post-IPO Debt - Sunshine Biopharma
RB Capital Partners
RB Capital Partners investment in Post-IPO Equity - Sunshine Biopharma
RB Capital Partners
RB Capital Partners investment in Post-IPO Debt - Sunshine Biopharma
Official Site Inspections
http://www.sunshinebiopharma.com Semrush global rank: 8.82 M Semrush visits lastest month: 460
- Host name: 172.67.135.83
- IP address: 172.67.135.83
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sunshine Biopharma"
Company – Sunshine Biopharma
333 Las Olas Way, CU4 Suite 433 Fort Lauderdale, FL 33301 USASee details»
Sunshine Biopharma - Crunchbase Company Profile
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative …See details»
Board of Directors – Sunshine Biopharma
Dr. Andrew M. Keller has served as a director of the Company since February 10, 2022. From 2016 through November 2019, Dr. Keller was the Chief Medical Officer at the Western …See details»
Sunshine Biopharma Inc, SBFM:NAQ profile - FT.com - Financial …
Nov 13, 2024 Sunshine Biopharma Inc (SBFM:NAQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Sunshine Biopharma - Craft
Oct 25, 2024 Sunshine Biopharma has 5 employees at their 1 location and $24.09 m in annual revenue in FY 2023. See insights on Sunshine Biopharma including office locations, …See details»
Meet the biotech firm, Sunshine Biopharma, that is …
Apr 13, 2022 A new option for treating COVID-19. Soon after the COVID-19 pandemic began in 2020, Sunshine Biopharma started working on a new antiviral drug. SBFM-PL4 targets an entirely different part of the ...See details»
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million ...
NEW YORK, NY / ACCESSWIRE / February 15, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life …See details»
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million …
MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company …See details»
Sunshine Biopharma Advances to Next Phase of Drug Development
Manufacturing Organization (CMO) and now is proceeding to conduct a series of requisite biological tests to ensure that the newly manufactured batch is identical to the original, not only …See details»
Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote
Find the latest Sunshine Biopharma, Inc. (SBFM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Sunshine Biopharma announces the acquisition of Nora Pharma, …
The acquisition of Nora Pharma brings Sunshine Biopharma closer to its objective of becoming a fully integrated pharmaceutical company. Montreal, Canada – (GLOBE NEWSWIRE) – …See details»
Sunshine Biopharma Enters Into a Collaboration Agreement
Nov 16, 2022 [email protected]. Sunshine Biopharma Media Contact: Christine Petraglia TraDigital IR Direct Line: 917-633-8980 …See details»
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove
Apr 5, 2022 [email protected] www.sunshinebiopharma.com. Tags CANCER VACCINE MRNA VACCINE TECHNOLOGY MULTIDRUG RESISTANT CANCER …See details»
For Immediate Release MANAGEMENT OF SUNSHINE
Organization, cancer is on the rise and has become a leading cause of death worldwide, accounting for 8.2 million deaths in 2012. Lung cancer accounted for 1.59 million deaths and …See details»
Sunshine Biopharma Launches a New Generic Prescription Drug
Nov 22, 2024 In addition, Sunshine Biopharma is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver …See details»
Sunshine Biopharma’s Newly Designed mRNA Molecules Prove …
Apr 5, 2022 A Potential Multi-Billion Dollar Global Market Opportunity for Cancer TreatmentsMONTREAL, April 05, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. …See details»
SBFM Stock Price Quote | Morningstar
3 days ago See the latest Sunshine Biopharma Inc stock price (SBFM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Press Release – Sunshine Biopharma
Apr 19, 2024 management of sunshine biopharma alarmed by the recent world health organization report that cancer is on the rise Feb 14, 2014 SUNSHINE BIOPHARMA BEGINS …See details»